Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$40.39 - $56.73 $465,858 - $654,323
-11,534 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$51.77 - $66.18 $49,233 - $62,937
951 Added 8.99%
11,534 $658,000
Q3 2020

Nov 16, 2020

BUY
$43.8 - $58.16 $125,530 - $166,686
2,866 Added 37.14%
10,583 $543,000
Q2 2020

Aug 14, 2020

BUY
$37.05 - $65.03 $285,914 - $501,836
7,717 New
7,717 $461,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.